Media

Piper Jaffray News Releases

 

News Releases  |  In the News

SHANGHAI, China, Nov. 2 /PRNewswire-FirstCall/ -- Piper Jaffray will host its first China Life Sciences Event on Wednesday, Nov. 15 in Shanghai. The event is co-hosted by O'Melveny & Myers LLP and Deloitte Touche.

The China Life Sciences Event, which showcases some of the most innovative companies in the life sciences sector, will provide investors and corporate executives a unique venue in which to hear first-hand about prospects, opportunities, risks and challenges in this growing health-related market segment.

The conference agenda includes presentation topics covering the growth of life sciences companies, attractive opportunities for institutional investors, pertinent considerations for companies in this sector and the changing life sciences climate in China.

Keynote addresses will be presented by Gerald Chan, chairman of the Morningside Group and Ren Dequan, former deputy commissioner of the State Food and Drug Administration (SFDA). Other presentations will highlight perspectives from venture and private equity investors, an analysis of the U.S. capital markets and updates from biopharmaceutical and medical device company executives. Additional topics will include: intellectual property protection and enforcement, the regulatory approval process, strategic alliances and strategies for mergers and acquisitions.

Companies scheduled to participate in the China Life Sciences Event include: Aura Partners, BioVeda Capital, Bridge Pharmaceuticals, Capital BioChip, China Medipharm, China Medical, ChongQing JingShan, Curis, Eli Lily, Fidelity Ventures, Green Valley, Hutchinson MediPharma Limited, IDG Technology Venture Investment, Lifetech Scientific, Medsphere, Microport Medical Co., Ltd., Morningside Group, Otsuka China, Pfizer, Profex, SAIF Partners, SIG Capital Limited, Simcere Pharmaceuticals, Sinocro Partners Limited, Summit Life Sciences, Sunway Biotech Co., Ltd., TongJiTang and WI Harper Group.

Company and investor participation in the China Life Sciences Event is by invitation only. Piper Jaffray clients interested in attending should contact their Piper Jaffray representative.

About Piper Jaffray

Piper Jaffray Companies is a leading, international middle market investment bank and institutional securities firm, serving the needs of middle market corporations, private equity groups, public entities, nonprofit clients and institutional investors. Founded in 1895, Piper Jaffray provides a comprehensive set of products and services, including equity and debt capital markets products; public finance services; mergers and acquisitions advisory services; high-yield and structured products; institutional equity and fixed-income sales and trading; and equity and high-yield research. With headquarters in Minneapolis, Piper Jaffray has 25 offices across the United States and international locations in London, Madrid and Shanghai. The firm's UK operating subsidiary, Piper Jaffray Ltd., is authorized and regulated by the Financial Services Authority and is a member of the London Stock Exchange. Piper Jaffray & Co. is the firm's principal operating subsidiary. (NYSE: PJC) ( http://www.piperjaffray.com )

Since 1895. Member SIPC and NYSE.

SOURCE Piper Jaffray

NOTE TO EDITORS:
Members of the media who would like to attend should contact
Susan Beatty Media Relations, of Piper Jaffray
at 612-303-5680 or susan.l.beatty@pjc.com .
Web site: http://www.piperjaffray.com